Cardiol Therapeutics Inc. - COM CL A (CRDL)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / COM CL A
Number of holders
30
Total Shares
6.83M
Shares change
+513K
Total reported value, excl. options
$5.92M
Value change
+$428K
Put/Call ratio
0.04
Number of buys
7
Number of sells
-10
Price
$0.84
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.